HKG:TCOM 14 January 2026

June 21, 2026, 3:05 AM EDT. AstraZeneca, RELX, and another leading FTSE stock stand out as strong picks for beginner investors in 2026. AstraZeneca, a global pharmaceutical giant, boasts a 'best in class' drug pipeline with a raised price target of 16,500p by Bank of America, highlighting potential sales growth despite risks from clinical trial outcomes. RELX, an information analytics provider embedding AI into its platforms, is seen as a 'mis-priced AI beneficiary' with shares trading below historical multiples after a tough 2025. These companies offer durable moats and growth prospects, but investors should weigh optimisms against inherent risks like clinical failures and AI adoption speed.